bepridil has been researched along with Sensitivity and Specificity in 3 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bepridil is highly effective in terminating persistent atrial fibrillation (AF)." | 7.75 | Pharmacological cardioversion preceding left atrial ablation: bepridil predicts the clinical outcome following ablation in patients with persistent atrial fibrillation. ( Isobe, M; Kobori, A; Kuwahara, T; Miyazaki, S; Sato, A; Takahashi, A; Takahashi, Y; Takei, A, 2009) |
| "Bepridil is highly effective in terminating persistent atrial fibrillation (AF)." | 3.75 | Pharmacological cardioversion preceding left atrial ablation: bepridil predicts the clinical outcome following ablation in patients with persistent atrial fibrillation. ( Isobe, M; Kobori, A; Kuwahara, T; Miyazaki, S; Sato, A; Takahashi, A; Takahashi, Y; Takei, A, 2009) |
| "Pilsicainide and bepridil were effective in 19 and 20 patients, respectively." | 2.74 | Predicting the efficacy of antiarrhythmic agents for interrupting persistent atrial fibrillation according to spectral analysis of the fibrillation waves on the surface ECG. ( Fujiki, A; Fukaya, H; Hatakeyama, Y; Izumi, T; Kiryu, M; Kurokawa, S; Niwano, H; Niwano, S; Sasaki, T, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamandis, P | 1 |
| Wildenhain, J | 1 |
| Clarke, ID | 1 |
| Sacher, AG | 1 |
| Graham, J | 1 |
| Bellows, DS | 1 |
| Ling, EK | 1 |
| Ward, RJ | 1 |
| Jamieson, LG | 1 |
| Tyers, M | 1 |
| Dirks, PB | 1 |
| Niwano, S | 1 |
| Sasaki, T | 1 |
| Kurokawa, S | 1 |
| Kiryu, M | 1 |
| Fukaya, H | 1 |
| Hatakeyama, Y | 1 |
| Niwano, H | 1 |
| Fujiki, A | 1 |
| Izumi, T | 1 |
| Miyazaki, S | 1 |
| Kuwahara, T | 1 |
| Kobori, A | 1 |
| Takahashi, Y | 1 |
| Takei, A | 1 |
| Sato, A | 1 |
| Isobe, M | 1 |
| Takahashi, A | 1 |
1 trial available for bepridil and Sensitivity and Specificity
| Article | Year |
|---|---|
Predicting the efficacy of antiarrhythmic agents for interrupting persistent atrial fibrillation according to spectral analysis of the fibrillation waves on the surface ECG.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Cross-Over Studies; Electrocardiography | 2009 |
2 other studies available for bepridil and Sensitivity and Specificity
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic | 2007 |
Pharmacological cardioversion preceding left atrial ablation: bepridil predicts the clinical outcome following ablation in patients with persistent atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Catheter Ablation; Chronic Disease; Electroca | 2009 |